China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm. The vaccine is the first one approved for general use in China.
Chen Shifei, the deputy commissioner of China’s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night. The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that trials had shown it to be 79.3% effective.